Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 12, 2016 7:03 PM ET

Company Overview of University of Birmingham

Company Overview

A U.K. university, is active in life science research and technology transfer to the private sector

Edgbaston

Birmingham,  B15 2TT

United Kingdom

Founded in 1900

Phone:

44 12 1414 3344

Fax:

44 12 1414 3344

Key Executives for University of Birmingham

University of Birmingham does not have any Key Executives recorded.

University of Birmingham Key Developments

Cell Therapy Catapult, University of Birmingham and Cancer Research Technology Launch New Collaboration for CAR-T Cell Immuno-Oncology Therapy Development

The Cell Therapy Catapult, the University of Birmingham and Cancer Research Technology, the commercialization arm of Cancer Research UK, announced the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours. The project is aimed at translating an academic discovery programme funded by Cancer Research UK and developed by Dr. Steven Lee and Prof Roy Bicknell at the University of Birmingham into a commercially viable cell therapy. The collaborating partners have launched a new company, Chimeric Therapeutics Ltd. This new company will hold all future IP rights to the resultant discoveries. The project is based on a new generation chimeric antigen receptor T-Cell (CAR-T) immuno-oncology therapy for solid tumours. This involves directing the CAR-T cell towards a new, highly specific marker of tumour angiogenesis, CLEC14a. This therapy will act as a vasculature disruptive agent compromising oxygen supply to the tumours and inhibiting tumour growth. The technology is currently undergoing the final stages of preclinical development, and is planned to enter into clinical trials soon after. Cancer Research Technology and the University of Birmingham have partnered with The Cell Therapy Catapult to bring their extensive regulatory, clinical, analytical and manufacturing process development expertise into the program, utilizing their experience in developing immunotherapies for cancer. The Cell Therapy Catapult will specifically be involved in the project to accelerate the translation of the academic discoveries made in Birmingham with Cancer Research Technology around CAR-T immunotherapies for solid tumours and the CLEC14a target towards a commercially available cell therapy.

University of Birmingham and Beijing Jiaotong University Signs Research Cooperation Agreement

The University of Birmingham and Beijing Jiaotong University (BJTU) have signed a research cooperation agreement that announced plans for a joint international high-speed railway research laboratory. The new research lab will be run jointly by the Birmingham Centre for Railway Research and Education (BCRRE) at the University of Birmingham - which offers the academic research and education capability for railways in the UK - and the State Key Lab of Rail Traffic Control and Safety at BJTU. The joint lab is expected to be developed as part of a wider UK-China high-speed railway research platform which will eventually bring together experienced railway researchers from other institutions from both nations with railway expertise. The aim is for the platform to deliver, in partnership, leading railway research for the global industry. The University of Birmingham has a history of research and collaboration with BJTU, especially in the area of railways. There have already been several academic exchanges between the two universities, which have come as a result of joint research projects funded by both the governments and industry of the UK and China. The Sino-UK Higher Education Research Partnership for PhD studies project supports the exchange of six researchers and six students between both the University of Birmingham and BJTU who work on advanced technologies to improve capacity and reduce consumption for metro systems.

University of Birmingham Announces Directorate Changes

The University of Birmingham announced the appointment of Dr. Judith Smith as the new Director of the Health Services Management Centre, succeeding Professor Jon Glasby. Dr. Smith joins the University from leading independent charitable research foundation the Nuffield Trust, where she has spent six years as Director of Policy. Prior to joining the Trust, Smith spent 14 years at HSMC, holding the positions of Senior Lecturer, Director of Research, and Academic Director of the NHS Management Training Scheme. From 2007 to 2009, Judith was based in New Zealand at the Victoria University of Wellington and the New Zealand Ministry of Health. Early in her career she was a senior manager in the NHS.

Similar Private Companies By Industry

Company Name Region
Castmaster Roll Co Ltd Europe
Duck & Rice Limited Europe
Gesban UK Limited Europe
Hovercraft Consultants Limited Europe
EvoCapital Advisors, LLP Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact University of Birmingham, please visit www.bham.ac.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.